Current Implications of Abnormal Bone Pathology: Consequences and Therapy

World Congress of Nephrology (ASN/ISN), San Francisco, CA, October, 2001
Access to this program is free but HDCN free zone registration is required.
Osteoporosis in ESRD
Sharon M. Moe, MD
Skeletal and Non-Skeletal Effects of Secondary Hyperparathyroidism
Kevin J. Martin, MB, BCh
Vitamin D Analogs
Eduardo Slatopolsky, MD
Questions and Answers
Speakers and moderators

After participating in this activity, participants should be able to:

Discuss the prevalence and causes of osteoporosis in ESRD;
Summarize the skeletal effects of parathyroid hormone in uremia;
Describe the non-skeletal effects of parathyroid hormone and how these might be related to uremia;
Understand the differences between currently used vitamin D analogs used to treat hyperparathyroidism in ESRD patients.

Kevin J. Martin, MB, BCh
Professor of Internal Medicine
Director, Division of Nephrology
Saint Louis University, St. Louis, MO

Sharon M. Moe, MD
Associate Professor of Medicine
Indiana University and Roudebush VAMC
Indianapolis, IN

Eduardo Slatopolsky, MD
Professor of Medicine
Washington University School of Medicine
St. Louis, MO



Post-test and evaluation form are at this link, but you must listen to all talks from this symposium prior to completing the test.
CME: Access Medical Group, Ltd. is accredited by the Accreditation Council for Continuing Medical Education (AACME) to sponsor continuing medical education for physicians. Access Medical Group, Ltd. designates this educational activity for up to 2.0 hours in category 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those hours of credit actually spent in the educational activity.

CEU: These talks are also designated to provide 2.0 hours of CEU Nursing Education credits, sponsored by the Renal Education Association. The Renal Education Association is accredited by the State of California Board of Nursing to provide continuing education for nurses (Provider number: CEP 13092).

Posting date: March 1, 2002.
Review date: March 1, 2003

Participation in this self-study activity should be completed in approximately two (2.0) hours. There are no fees for participating and receiving CME or CEU credit for this activity. To successfully complete this activity and receive credit, participants must follow these steps during the period March 1, 2002 through March 1, 2003.
1. Register for continuing education credit by completing the registration process.
2. Read the goals and learning objectives.
3. Read the article text and tables, and review figures.
4. Read, complete, and submit answers to the post test questions and evaluation questions. You must receive a test score of at least 75% and respond to all evaluation questions to receive your online CME or CEU certificate.

The primary target audience is physicians involved in the care of renal patients (CME), and nephrology nurses, dietitians, dialysis technicians and pharmacists (CEU).

All faculty participating in continuing medical education programs are expected to disclose to the program audience any real or apparent conflict of interest related to the subject under discussion. The faculty disclosure information is as follows:
Martin, Kevin: Grants: Abbott, Amgen. Consultantships: Abbott, Amgen. Honoraria: Abbott.
Moe, Sharon: Grants or research support: Amgen. Consultantships: Genzyme, Amgen, Bone Care International, Abbott; stocks: Lilly; honoraria: Genzyme, Amgen, Bone Care International, Abbott
Slatopolsky, Eduardo: Grant support: Abbott, Geltey. Consutantships: Genzyme. Stocks: Merck, Pfizer, Amgen. Honoraria: Abbott, Genzyme. Funding: Various pharmaceutical companies.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. Access Medical Group, Ltd., ASN, HDCN and the Renal Education Association do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

This educational activity is supported by an educational grant from Abbott Renal Care.
This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies and with CE policies of the State of California Board of Registered Nursing.
This educational activity is an approved ASN/ISN Satellite Symposium. It was not planned by the World Congress of Nephrology program committee.